Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 752

Results For "ED"

8126 News Found

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
Drug Approval | September 29, 2021

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9

India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys


Digital health-start-up MFine raises US $ 48 million
Startup | September 29, 2021

Digital health-start-up MFine raises US $ 48 million

Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions


Lupin launches Droxidopa capsules in the US
Drug Approval | September 29, 2021

Lupin launches Droxidopa capsules in the US

Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA


Thermo Fisher launches SpeciMAX saliva collection kit
Medical Device | September 29, 2021

Thermo Fisher launches SpeciMAX saliva collection kit

The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection


Eisai initiates rolling submission for Biological Licence Application of Lecanemab
Biotech | September 28, 2021

Eisai initiates rolling submission for Biological Licence Application of Lecanemab

The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology


Zymo Research donates one million Covid-19 test kits to Mapmygenome
News | September 28, 2021

Zymo Research donates one million Covid-19 test kits to Mapmygenome

Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries


Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
Drug Approval | September 28, 2021

Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer

Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low


Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
News | September 28, 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports


Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research
Healthcare | September 28, 2021

Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research

As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters


Bal Pharma ramps up API capacity of Gliclazide
News | September 28, 2021

Bal Pharma ramps up API capacity of Gliclazide

In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report